To overcome the lack of specific immunity cells (T, B and NK) in the microenvironment of the tumor xenograft, and the failure of this model in assessing the role of such immune cells in IL30-conditioned tumor, we then used a fully immunocompetent model of cancer induced by TRAMP-C1 cells in C57BL/6J host. The gene discussed is IL27; the disease is neoplasm.